Kistamicin biosynthesis reveals the biosynthetic requirements for production of highly crosslinked glycopeptide antibiotics

0303 health sciences 1300 Biochemistry Science Q Glycopeptides General Physics and Astronomy Genetics and Molecular Biology General Chemistry 1600 Chemistry 540 Article Anti-Bacterial Agents Biosynthetic Pathways 3. Good health Actinobacteria 03 medical and health sciences Bacterial Proteins Cytochrome P-450 Enzyme System Cyclization Multigene Family General Biochemistry Biocatalysis 3100 Physics and Astronomy Peptides
DOI: 10.1038/s41467-019-10384-w Publication Date: 2019-06-13T10:02:28Z
ABSTRACT
AbstractKistamicin is a divergent member of the glycopeptide antibiotics, a structurally complex class of important, clinically relevant antibiotics often used as the last resort against resistant bacteria. The extensively crosslinked structure of these antibiotics that is essential for their activity makes their chemical synthesis highly challenging and limits their production to bacterial fermentation. Kistamicin contains three crosslinks, including an unusual 15-membered A-O-B ring, despite the presence of only two Cytochrome P450 Oxy enzymes thought to catalyse formation of such crosslinks within the biosynthetic gene cluster. In this study, we characterise the kistamicin cyclisation pathway, showing that the two Oxy enzymes are responsible for these crosslinks within kistamicin and that they function through interactions with the X-domain, unique to glycopeptide antibiotic biosynthesis. We also show that the kistamicin OxyC enzyme is a promiscuous biocatalyst, able to install multiple crosslinks into peptides containing phenolic amino acids.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (64)
CITATIONS (59)